RAPT Therapeutics, Inc.
RAPT
$31.90
-$0.43-1.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.62% | 36.22% | 43.76% | -72.46% | 41.25% |
| Total Depreciation and Amortization | -30.98% | -25.25% | -19.75% | -11.15% | -8.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.83% | -17.99% | -9.20% | 22.54% | 37.28% |
| Change in Net Operating Assets | 103.55% | 130.97% | -2,034.33% | 3,926.46% | -170.23% |
| Cash from Operations | 29.30% | 59.97% | -93.52% | 62.39% | 19.48% |
| Capital Expenditure | 100.00% | -4,100.00% | 59.05% | 98.51% | 74.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.14% | -137.59% | -456.56% | -104.07% | -28.48% |
| Cash from Investing | -54.10% | -137.79% | -459.19% | -104.08% | -28.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -77.03% | -- | 31,147.82% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -77.03% | -- | 31,147.82% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -580.68% | -122.95% | -4,966.08% | 2,080.40% | -79.27% |